India is rapidly emerging as a global player in biopharmaceutical innovation, diagnostics, and vaccine manufacturing. Yet, amid this growth lies a quiet but critical bottleneck: our dependency on imported biological reagents.
From ELISA kits and monoclonal antibodies to cell culture media and detection assays — the majority of critical reagents used in India’s biotech and pharma labs are sourced from overseas. This reliance poses challenges not only in terms of cost, but also in speed, consistency, and regulatory traceability.
The Problem ?
Importing reagents is no longer working.
India’s biotech ecosystem is innovating faster than ever, but our reagent supply chains have not caught up. Most R&D labs, CROs, and diagnostic manufacturers still rely on reagents from the US, Europe, or China.
Here’s what that creates:
1. Long Lead Times
Waiting 4–8 weeks for a critical ELISA pair or a batch of cell culture media can delay entire project timelines — especially in clinical validation or biosimilar development.
2. High Costs
Import duties, shipping, temperature-sensitive packaging, and markups can make even basic reagents 2–3x more expensive than local manufacturing would allow.
3. Regulatory & Quality Risks
For assays used in diagnostics or regulated bioanalytical studies, traceability and lot-to-lot consistency are non-negotiable. Delays in CoAs or inconsistent batches from imports can create compliance risks.
4. IP & Customization Challenges
Imported solutions often come as “black box” kits with little flexibility. This limits your ability to tailor reagents for specific platforms, antigens, or applications.
The Opportunity ??
India’s diagnostics and biologics industry is projected to grow to $120 billion+ by 2030. To keep up, we need indigenous, world-class suppliers of critical reagents who can meet both the technical bar and the delivery demand.
Benefits of Local Manufacturing:
- Faster turnaround (weeks, not months)
- Custom development for local clinical targets
- Regulatory-aligned QC and documentation
- Stronger IP control
- Better price-performance ratios
- Reliable technical support in your timezone
That’s where we step in.
How are we doing it?
At Denovo Biolabs, we’re committed to providing globally benchmarked reagents, made in India. Our in-house facilities in Bangalore are equipped to design, validate, and manufacture critical reagents tailored to your application — whether that’s an ELISA kit, monoclonal antibody, or serum-free culture media.
1. Custom Antibody Development (Monoclonal & Polyclonal) ?
- Target-specific antibody design
- Immunogen synthesis, hybridoma screening, and affinity purification
- Validation for use in ELISA, flow cytometry, Western blotting, and diagnostics
- Rapid delivery of small-scale research batches or scale-up for commercial kits
Ideal for biosimilar PK/ADA studies, diagnostic kits, biomarker validation.
2. ELISA Kits for PK, HCP and Diagnostic Targets ?
- Ready-to-use or custom-developed quantitative ELISAs
- Optimized for sensitivity (LOD < 1 ng/mL), specificity, and matrix compatibility
- Validated across serum/plasma for regulated environments
- Comprehensive assay documentation and QC metrics
Used in clinical CROs, vaccine R&D, and biosimilar trials.
3. CHO Host Cell Protein Detection ?
- Fit-for-purpose anti-HCP antibody generation
- ELISA and orthogonal LC-MS-based workflows
- Designed to meet ICH Q6B and EMA/FDA guidelines
- Full development support for your biologic pipeline
A must for GMP biologics, biosimilars, and regulatory submissions.
4. Cell Culture Media
- Optimized for CHO, HEK, hybridoma, and primary cells
- Lot-to-lot consistency and performance validation
- Custom formulations based on your cell line and productivity needs
- Cost-efficient alternative to imported media, without compromising quality
Perfect for stable clone selection, media trials, and production-scale runs.
Why choose us?
By choosing Denovo’s Made-in-India reagents, our partners benefit from:
- Faster R&D cycles ?
- Lower assay costs without cutting corners ?
- Streamlined regulatory audits (with full QC support) ?
- Direct scientific consultation & customization ?
- Reduced dependence on unpredictable international shipping ?
We supply reagents and become your scientific partner, co-developing solutions that are practical, compliant, and performance-driven.
The next decade of biotech belongs to India — but to lead globally, we must first build resilient, high-quality foundations locally.
Critical reagents are no longer consumables, they are strategic assets. We are proud to be one of the few companies in India delivering the scientific rigour, validation standards, and customizability our ecosystem needs to compete globally.
Ready to Replace Your Imported Reagents?
Visit our website and fill out the contact form to discuss your project or request a quote.
Let’s build a self-reliant biotech ecosystem.